Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Sabre Insurance Group (SBRE) by Berenberg
- Hold Close Brothers Group (CBG) by Shore Capital
- Buy Lloyds Banking Group (LLOY) by Redburn
- Hold Marks & Spencer Group (MKS) by Berenberg
- Overweight Marks & Spencer Group (MKS) by Barclays
- Overweight Prudential (PRU) by Barclays
- Equal Weight Avon Technologies (AVON) by Barclays
- Buy Pearson (PSON) by Goldman Sachs
- Neutral Dr. Martens (DOCS) by Goldman Sachs
- Neutral Ithaca Energy (ITH) by Goldman Sachs
- Buy Marks & Spencer Group (MKS) by Goldman Sachs
- Buy Vesuvius (VSVS) by Berenberg
- Buy Central Asia Metals (CAML) by Berenberg
- Buy Marks & Spencer Group (MKS) by UBS
- Overweight WH Smith (SMWH) by JP Morgan
- Overweight SSE (SSE) by JP Morgan
- Buy Marks & Spencer Group (MKS) by Jefferies
- Hold Sainsbury (J) (SBRY) by Jefferies
- Buy JD Sports Fashion (JD.) by Shore Capital
- Hold Avon Technologies (AVON) by Shore Capital
ReNeuron Group (RENE) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for ReNeuron Group (RENE)
| Latest Bid : 3.25p | Latest Ask : 3.50p |
| High Today : 3.50p | Low Today : 3.27p |
| This Years High : 11.12p | This Years Low : 3.27p |
| Volume : 177,374 | MKT Cap : £1.93M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
24/01/2018 – Stock Consolidation 100.000:1.000
ReNeuron Group (RENE) Overview
ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.ReNeuron Group (RENE) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Nigel Somerville | Premium Only | 2023-11-09 08:40:00 09/11/2023 | 35.10% |
| Risky Buy | Peter Stephens | Premium Only | 2016-12-05 14:11:43 05/12/2016 | -60.62% |
| Buy | N+1 Singer | Premium Only | 2014-12-10 11:23:25 10/12/2014 | 78.57% |
ReNeuron Group (RENE) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 3.25p | Latest Ask : 3.50p |
| High Today : 3.50p | Low Today : 3.27p |
| This Years High : 11.12p | This Years Low : 3.27p |
| Volume : 177,374 | MKT Cap : £1.93M |
ReNeuron Group Overview
ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest ReNeuron Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Nigel Somerville | Premium Only | 2023-11-09 08:40:00 09/11/2023 | 35.10% |
| Risky Buy | Peter Stephens | Premium Only | 2016-12-05 14:11:43 05/12/2016 | -60.62% |
| Buy | N+1 Singer | Premium Only | 2014-12-10 11:23:25 10/12/2014 | 78.57% |
Stock Splits and Consolidations
24/01/2018 – Stock Consolidation 100.000:1.000